Erectile dysfunction Posts on Medivizor

Posted by Medivizor on Feb 27, 2023 in Erectile dysfunction | 0 comments

In a nutshell This study compared the effectiveness and safety of intralesional verapamil (Calan; ILV) and collagenase Clostridium histolyticum (Xiaflex; CCH) injections in men with Peyronie’s disease (PD). The data showed that CCH therapy was more effective than ILV, with a higher high level of patient satisfaction rate in the short term...

Posted by Medivizor on Dec 4, 2022 in Erectile dysfunction | 0 comments

In a nutshell This study evaluated the effectiveness of combining low-intensity extracorporeal shock wave therapy (Li-ESWT) with a vacuum erectile device (VED) for the treatment of patients with diabetes mellitus (DM) and erectile dysfunction (ED) who were unresponsive to phosphodiesterase-5 (PDE5) inhibitors. The data showed that Li-ESWT combined with...

Posted by Medivizor on Oct 7, 2022 in Erectile dysfunction | 0 comments

In a nutshell This study evaluated the effectiveness and safety of low-intensity extracorporeal shock wave therapy (Li-ESWT) for patients with diabetes and erectile dysfunction (ED). The data showed that Li-ESWT was safe and effective in improving the symptoms of ED in these patients. Some background Erectile dysfunction (ED) consists of the inability...

Posted by Medivizor on Apr 26, 2022 in Erectile dysfunction | 0 comments

In a nutshell This study compared the effectiveness and safety of avanafil (Stendra) with sildenafil (Viagra) for the treatment of patients with erectile dysfunction (ED). The data showed that avanafil had higher effectiveness compared to sildenafil in improving the symptoms of ED after 12 weeks. Some background Erectile dysfunction...

Posted by Medivizor on Apr 10, 2022 in Erectile dysfunction | 0 comments

In a nutshell This study evaluated the effectiveness and safety of low-intensity extracorporeal shock wave therapy (LSWT) for patients with chronic pelvic pain syndrome (CPPS) and erectile dysfunction (ED). The data showed that LSWT was safe and effective in improving the symptoms of these patients. Some background CPPS is lower abdominal pain usually...

Posted by Medivizor on Mar 20, 2022 in Erectile dysfunction | 0 comments

In a nutshell This study investigated the effectiveness and safety of combining low-intensity extracorporeal shock wave therapy (Li-ESWT) with tadalafil (Cialis) and L-arginine for the treatment of patients with mild and moderate erectile dysfunction (ED). The data showed that daily therapy with tadalafil and L-arginine increased the...

Posted by Medivizor on Jul 9, 2021 in Erectile dysfunction | 0 comments

In a nutshell This study investigated the effectiveness of RestoreX penile traction device in the treatment of penile complications after prostate surgery. Researchers suggested that RestoreX improves penis length and sexual function after prostate surgery.  Some background Prostate surgery can impact male sexual function. The effects can go from...

Posted by Medivizor on Apr 25, 2021 in Erectile dysfunction | 0 comments

In a nutshell This study reviewed the best phosphodiesterase type 5 inhibitors (PDE5is) for the treatment of erectile dysfunction (ED) after prostate surgery. Researchers suggested that avanafil (Spedra) might be the best PDE5i drug for these patients. Some background Prostate cancer is one of the most common cancers in the elderly population. ED...

Posted by Medivizor on Apr 11, 2021 in Erectile dysfunction | 0 comments

In a nutshell This review compared the outcomes of different combined therapy for erectile dysfunction (ED). Researchers suggested that a combination of phosphodiesterase 5 inhibitor (PDE5i) and antioxidants is safe and associated with improved outcomes in these patients.  Some background ED consists of the inability of getting and...

Posted by Medivizor on Apr 10, 2021 in Erectile dysfunction | 0 comments

In a nutshell This study compared the effectiveness of two different types of xenografts (transplant of a tissue or organ derived from an animal) in the treatment of Peyronie’s disease (PD). Researchers suggested that xenografts might be a good and safe treatment option for these patients. Some background PD is a disorder in which scar...

Posted by Medivizor on Apr 4, 2021 in Erectile dysfunction | 0 comments

In a nutshell This study investigated the effectiveness and safety of Collagenase Clostridium histolyticum (CCH) in the treatment of acute phase Peyronie’s disease (PD). Researchers suggested that CCH therapy improves the outcomes of these patients. Some background PD consists of the formation of scar tissue inside the penis. It affects...